Over the past 2 years the global pharmaceutical industry has been shifting its focus towards the emerging market such as India. The CRAMS segment in India is expected to be one of the biggest beneficiaries of this wave. This study presents a comprehensive study of the Indian contract research and manufacturing services market from drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectable in India. The study is built from detailed primary research - including evaluation of market size and components with those, as well as market opportunities to enable decisions with regards to future strategic direction and investment in the 2010–2015 period.
Introduction to the Study
- Introduction
Scope of the Study
- Scope of Study and Introduction
Industry Overview- Contract Manufacturing
- Industry Overview
- Drivers and Restraints
- Emerging Trends
Industry Overview- Contact Research
- Overview
- Drivers and Restraints
- Emerging Trends
Key Indian Players
- Contract Research and Contract Manufacturing Organizations
Emerging Opportunity Areas
- Emerging Opportunities in the CRAMS Market
Global Pharmaceutical Market Scenario 2008
Growth Trends
R&D Costs
Drug Patent Expires
Introduction and Market Overview
Market Engineering Measurements
Industry Structure
Outsourcing Pharmaceutical Manufacturing: Benefit Analysis
Revenue Forecasts
Market Drivers
Market Restraints
Advantage India
- Introduction and Market Overview
APIs and Intermediates
Formulations
Solid Dosage Form
Liquid Dosage Form
Injectables
Conclusions
Recommendations
Divis Laboratory
Piramal Healthcare
Jubilant Organosys
Dishman Pharma
Aurobindo Pharma
Dr. Reddy’s Laboratories
Key Collaborations and M&A
Dynamics of the Indian CRO industry
Introduction
Industry Sponsor Scenario
Industry Analysis
Total Market
Contract Research Services - Chemistry
Contract Research Services - Biology
Contract Research Services- Pre Clinical
Market Dynamics
Competitive Structure of Contract Research Organizations
Syngene
Jubilant Life Sciences
GVK Biosciences
Aurigene
Sai Advantium
Chembiotek
Advinus Therapeutics
Suven Lifescience
Intox
Jai Research Foundation
Avra Labs
RCC Labs
Contract Research Market Analysis
Challenges Faced by CRO's
Strategic Recommendations
Frost & Sullivan Brief
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
Over the past 2 years the global pharmaceutical industry has been shifting its focus towards the emerging market such as India. The CRAMS segment in India is expected to be one of the biggest beneficiaries of this wave. This study presents a comprehensive study of the Indian contract research and manufacturing services market from drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectable in India. The study is built from detailed primary research - including evaluation of market size and components with those, as well as market opportunities to enable decisions with regards to future strategic direction and investment in the 20102015 period.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | P290-01-00-00-00 |
| Is Prebook | No |
Strategic Analysis of Contract Research and Manufacturing Services Market in India
Strategic Analysis of Contract Research and Manufacturing Services Market in India
RELEASE DATE
11-Oct-2010
11-Oct-2010
REGION
Asia Pacific
Asia Pacific
Deliverable Type
Market Research
Market Research
Research Code: P290-01-00-00-00
SKU: HC02289-AP-MR_08173
$4,950.00
In stock
SKU
HC02289-AP-MR_08173